Pharmaniaga Bhd (7081) - Total Liabilities
Based on the latest financial reports, Pharmaniaga Bhd (7081) has total liabilities worth RM1.87 Billion MYR (≈ $468.97 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 7081 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Pharmaniaga Bhd - Total Liabilities Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's total liabilities have evolved over time, based on quarterly financial data. See Pharmaniaga Bhd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Pharmaniaga Bhd Competitors by Total Liabilities
The table below lists competitors of Pharmaniaga Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Kan Specialities Material Co Ltd
SHE:002012
|
China | CN¥162.69 Million |
|
Jiangxi Sunshine Dairy Co Ltd
SHE:001318
|
China | CN¥77.85 Million |
|
Daesang Corp
KO:001680
|
Korea | ₩2.38 Trillion |
|
SFA Engineering Corporation
KQ:056190
|
Korea | ₩751.67 Billion |
|
Hebei Gongda Keya Energy Technology Co. Ltd. A
SHE:301197
|
China | CN¥339.40 Million |
|
Prisma Properties
ST:PRISMA
|
Sweden | Skr4.23 Billion |
|
Hollyland China Electronics Technology Corp Ltd
SHE:002729
|
China | CN¥113.99 Million |
|
Jiangsu Luokai Mechanical & Electrical Co Ltd Class A
SHG:603829
|
China | CN¥1.42 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Pharmaniaga Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 7081 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmaniaga Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmaniaga Bhd (2012–2025)
The table below shows the annual total liabilities of Pharmaniaga Bhd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | RM1.79 Billion ≈ $448.83 Million |
-16.40% |
| 2024-12-31 | RM2.14 Billion ≈ $536.84 Million |
-2.32% |
| 2023-12-31 | RM2.19 Billion ≈ $549.57 Million |
-0.30% |
| 2022-12-31 | RM2.20 Billion ≈ $551.24 Million |
+22.84% |
| 2021-12-31 | RM1.79 Billion ≈ $448.76 Million |
+43.84% |
| 2020-12-31 | RM1.24 Billion ≈ $311.98 Million |
-0.94% |
| 2019-12-31 | RM1.25 Billion ≈ $314.95 Million |
-10.29% |
| 2018-12-31 | RM1.40 Billion ≈ $351.09 Million |
+29.52% |
| 2017-12-31 | RM1.08 Billion ≈ $271.08 Million |
-6.31% |
| 2016-12-31 | RM1.15 Billion ≈ $289.35 Million |
+23.13% |
| 2015-12-31 | RM936.00 Million ≈ $235.00 Million |
+35.46% |
| 2014-12-31 | RM691.00 Million ≈ $173.49 Million |
+13.65% |
| 2013-12-31 | RM608.00 Million ≈ $152.65 Million |
-17.28% |
| 2012-12-31 | RM735.00 Million ≈ $184.53 Million |
-- |
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more